Clinical Trial Update: PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones [NA]

View source ↗

Summary

An ongoing PMCF study of MODULITH SLX-F2 with StorM-Track for kidney stones, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Stones
• Urolithiasis

Drugs mentioned

• MODULITH SLX-F2 with StorM-Track

Snippet

Sponsor: Storz Medical AG | Conditions: Kidney Stones, Urolithiasis | NA | Status: RECRUITING